---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-021342"
form_type: "8-K"
ticker: "NEPH"
cik: "0001196298"
company_name: "NEPHROS INC"
filed_at: "2024-05-24T23:59:59+00:00"
generated_at: "2026-06-01T08:36:15.460602+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Nephros stockholders approve 2024 Equity Incentive Plan authorizing 2,616,875 shares

## Summary
- Plan adds 900,000 new shares plus prior plan reserve and returning shares; total shares authorized 2,616,875.
- Stockholders elected directors Arthur H. Amron (6,860,037 for) and Oliver Spandow (6,690,864 for).
- Ratified Baker Tilly US, LLP as independent auditor for FY2024 (8,545,420 for, 21,330 against).
- Advisory say-on-pay approved with 6,832,340 for, 62,907 against.
- Prior plan no longer available for new grants; all outstanding awards remain subject to prior terms.

## SEC filing metadata
- accession: 0001493152-24-021342
- form_type: 8-K
- ticker: NEPH
- cik: 0001196298
- company_name: NEPHROS INC
- filed_at: 2024-05-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1196298/000149315224021342/0001493152-24-021342-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1196298/000149315224021342/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-021342
- JSON: https://secwatch.observer/filing/0001493152-24-021342.json
- Plain text: https://secwatch.observer/filing/0001493152-24-021342.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.